{
  "id": "17d5d915-05c6-43c4-bbd4-1682b5ee49c6",
  "university": "PCI",
  "regulation": "Master",
  "course": "B.Pharm",
  "effective_year": null,
  "curriculum_type": "pci",
  "curriculum_data": {
    "years": [
      {
        "year": 4,
        "semesters": [
          {
            "semester": 8,
            "subjects": [
              {
                "code": "BP804ET",
                "name": "Pharmaceutical Regulatory Science",
                "type": "theory",
                "category": "elective",
                "units": [
                  {
                    "number": "Unit I",
                    "title": "New Drug Discovery and Development",
                    "topics": [
                      "Stages of drug discovery",
                      "Drug development process",
                      "Pre-clinical studies",
                      "Non-clinical activities",
                      "Clinical studies",
                      "Innovator drugs",
                      "Generic drugs",
                      "Concept of generics",
                      "Generic drug product development"
                    ]
                  },
                  {
                    "number": "Unit II",
                    "title": "Regulatory Approval Process and Authorities",
                    "topics": [
                      "Approval process for Investigational New Drug (IND)",
                      "Timelines for Investigational New Drug (IND)",
                      "Approval process for New Drug Application (NDA)",
                      "Timelines for New Drug Application (NDA)",
                      "Approval process for Abbreviated New Drug Application (ANDA)",
                      "Timelines for Abbreviated New Drug Application (ANDA)",
                      "Changes to an approved NDA",
                      "Changes to an approved ANDA",
                      "Regulatory authorities of India",
                      "Regulatory authorities of United States",
                      "Regulatory authorities of European Union",
                      "Regulatory authorities of Australia",
                      "Regulatory authorities of Japan",
                      "Regulatory authorities of Canada",
                      "Organization structure of regulatory authorities",
                      "Types of applications for regulatory authorities"
                    ]
                  },
                  {
                    "number": "Unit III",
                    "title": "Registration in Overseas Market",
                    "topics": [
                      "Procedure for export of pharmaceutical products",
                      "Technical documentation for export",
                      "Drug Master Files (DMF)",
                      "Common Technical Document (CTD)",
                      "Electronic Common Technical Document (eCTD)",
                      "ASEAN Common Technical Document (ACTD)"
                    ]
                  },
                  {
                    "number": "Unit IV",
                    "title": "Clinical Trials",
                    "topics": [
                      "Developing clinical trial protocols",
                      "Institutional Review Board formation",
                      "Institutional Review Board working procedures",
                      "Independent Ethics committee formation",
                      "Independent Ethics committee working procedures",
                      "Informed consent process",
                      "Informed consent procedures",
                      "GCP obligations of Investigators",
                      "GCP obligations of sponsors",
                      "GCP obligations of Monitors",
                      "Managing clinical trials",
                      "Monitoring clinical trials",
                      "Pharmacovigilance in clinical trials",
                      "Safety monitoring in clinical trials"
                    ]
                  },
                  {
                    "number": "Unit V",
                    "title": "Regulatory Concepts",
                    "topics": [
                      "Basic terminology of regulatory concepts",
                      "Guidance documents",
                      "Guidelines",
                      "Regulations",
                      "Laws and Acts",
                      "Orange book",
                      "Federal Register",
                      "Code of Federal Regulatory",
                      "Purple book"
                    ]
                  }
                ]
              }
            ]
          }
        ]
      }
    ],
    "university": "Generic University",
    "regulation": "PCI Regulation",
    "course": "B.Pharm"
  },
  "stats": {
    "years": 4,
    "semesters": 8,
    "subjects": 1,
    "units": 5,
    "topics": 54,
    "theory": 1,
    "practical": 0,
    "electives": 0
  },
  "status": "active",
  "created_at": "2025-12-16T07:09:52.260885+00:00",
  "updated_at": null
}